MENLO PARK, CA, Clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious diseases, announced today the closing of its Series D round. more...
DALLAS, TX, Leading provider of cyber threat intelligence for global enterprises, today announced it has closed a $30 million Series C equity-financing round. more...
NEW YORK, NY, Artificial intelligence company, today announced that it has secured $9.2 Million in a Series A Financing led by FirstMark Capital. more...